TFS International AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TFS International AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10579
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TFS International AB (TFS International) is a contract research organization that provides clinical development solutions. The organization through its business areas, TFS Develop and TFS People, provides various services worldwide including clinical development planning, regulatory affairs, feasibility, study and site coordination, among others. It offers patient recruitment services, clinical data management, biostatistics, pharmacovigilance and safety, medical writing, training, quality assurance and functional service solutions, among others. TFS International offers therapeutic areas such as oncology, cardiovascular, dermatology, immunology, CNS, endocrinology and ophthalmology, among others. The organization offers scientific advice, product development consulting, protocol design, and other services. It operates through regional and sales offices in Sweden and the US. TFS International is headquartered in Lund, Sweden

TFS International AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TFS International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TFS International AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TFS International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TFS International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TFS International AB, Medical Devices Deals, 2012 to YTD 2018 9
TFS International AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TFS International AB, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
TFS Trial Form Support International Completes Acquisition Of Contract Research Business Of Semcon Caran 11
Private Equity 13
Ratos to Acquire 60% Stake in TFS International 13
Partnerships 14
Araclon Biotech Enters into Agreement with TFS International 14
TiGenix Forms Partnership with TFS International 15
TFS Enters into Agreement with SCIderm for Dermatology Trials 16
Acquisition 17
TFS International Acquires SCIderm 17
TFS Trial Form Support International Acquires Beardsworth Consulting, Contract Research Organization 18
TFS Trial Form Support International Acquires Dimensione Ricerca, Clinical CRO 19
TFS International AB – Key Competitors 20
TFS International AB – Key Employees 21
TFS International AB – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Corporate Communications 24
Jun 20, 2018: TFS International Names Dr Suzanne Pavon As Executive Vice President, Quality Assurance 24
Apr 03, 2018: TFS International appoints Dr Andrew Copestake as Chief Commercial Officer 25
Jan 10, 2018: TFS International Appoints New Chief Executive Officer 26
Jul 13, 2017: TFS International Appoints Mr. Ryan Shortreed as Chief Financial Officer, Mr. Martin Filippides as Vice President Human Resources and Mr. Young Shon as Chief Information Officer 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
TFS International AB, Pharmaceuticals & Healthcare, Key Facts 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TFS International AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TFS International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TFS International AB, Deals By Therapy Area, 2012 to YTD 2018 8
TFS International AB, Medical Devices Deals, 2012 to YTD 2018 9
TFS International AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TFS Trial Form Support International Completes Acquisition Of Contract Research Business Of Semcon Caran 11
Ratos to Acquire 60% Stake in TFS International 13
Araclon Biotech Enters into Agreement with TFS International 14
TiGenix Forms Partnership with TFS International 15
TFS Enters into Agreement with SCIderm for Dermatology Trials 16
TFS International Acquires SCIderm 17
TFS Trial Form Support International Acquires Beardsworth Consulting, Contract Research Organization 18
TFS Trial Form Support International Acquires Dimensione Ricerca, Clinical CRO 19
TFS International AB, Key Competitors 20
TFS International AB, Key Employees 21
TFS International AB, Subsidiaries 22

List of Figures
TFS International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TFS International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TFS International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TFS International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TFS International AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TFS International AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • J & J Snack Foods Corp:企業の戦略・SWOT・財務情報
    J & J Snack Foods Corp - Strategy, SWOT and Corporate Finance Report Summary J & J Snack Foods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Navidea Biopharmaceuticals Inc (NAVB):医療機器:M&Aディール及び事業提携情報
    Summary Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline prod …
  • XOMA Corp (XOMA):製薬・医療:M&Aディール及び事業提携情報
    Summary XOMA Corp (Xoma), formerly Xoma Ltd, is a biopharmaceutical company that develops antibody-based therapeutics. Its lead product, gevokizumab is a monoclonal antibody used for the treatment of a wide variety of inflammatory diseases and other diseases. Its other pipeline products include X358 …
  • Mitsubishi Estate Co., Ltd.:企業の戦略・SWOT・財務分析
    Mitsubishi Estate Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Estate Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • AnaBios Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization that offers drug efficacy studies on human samples. The organization’s products portfolio includes human dorsal root ganglia neuron cultures, human cardiac mesenchymal stem cells, human heart tissue samples, human …
  • Wallenstam AB (WALL B):企業の財務・戦略的SWOT分析
    Summary Wallenstam AB (Wallenstam) is a construction company that offers building and property management solutions. The company's services include commercial and residential properties development, housing programs, property investment and management, urban development, property ownership services, …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Dauntless Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dauntless Pharmaceuticals Inc (Dauntless Pharma) is a drug development company that develops therapeutic agents. The company’s pipeline products include DP1038 and DP2018. Its DP1038 is an intranasal octreotide formulation used as a therapeutic agent for the treatment of acromegaly and neuro …
  • FutureFuel Corp (FF):企業の財務・戦略的SWOT分析
    FutureFuel Corp (FF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Harry Ramsden’s:企業の戦略・SWOT・財務分析
    Harry Ramsden's - Strategy, SWOT and Corporate Finance Report Summary Harry Ramsden's - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Club Mediterranee SA:戦略・SWOT・企業財務分析
    Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report Summary Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Altium Ltd:企業の戦略・SWOT・財務情報
    Altium Ltd - Strategy, SWOT and Corporate Finance Report Summary Altium Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Motif Bio Plc (MTFB):製薬・医療:M&Aディール及び事業提携情報
    Summary Motif Bio Plc (Motif Bio), formerly Motif Bio Ltd, is a clinical-stage biopharmaceutical company that focuses on the development of novel antibiotics to treat patients with infections caused by multi-drug resistant bacteria. The company develops Iclaprim, a targeted Gram-positive1 antibiotic …
  • Eutelsat Communications S.A. (ETL):企業の財務・戦略的SWOT分析
    Eutelsat Communications S.A. (ETL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bird Construction Inc (BDT):企業の財務・戦略的SWOT分析
    Bird Construction Inc (BDT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Transportes Aereos Portugueses, SGPS, SA:企業の戦略・SWOT・財務情報
    Transportes Aereos Portugueses, SGPS, SA - Strategy, SWOT and Corporate Finance Report Summary Transportes Aereos Portugueses, SGPS, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Seadrill Limited (SDRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Seadrill Limited (Seadrill) is an offshore drilling contractor. The company provides contract drilling, well services and engineering services to offshore exploration and production companies. Its fleet includes drillships, jack-up rigs, semi-submersibles, and tender rigs for operations in s …
  • Cortec GmbH:企業の製品パイプライン分析2018
    Summary Cortec GmbH (Cortec), a subsidiary of Iron Force Industrial Co Ltd, is a medical engineering company that develops neurons technology platform for the measurement and stimulation of brain activity. The company develops implants that serve as a direct interface between brain and technology. I …
  • Constellation Software Inc (CSU):企業の財務・戦略的SWOT分析
    Constellation Software Inc (CSU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • The J.M. Smucker Co:戦略・SWOT・企業財務分析
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆